🇺🇸 US Stock Screener ← Switch market ⚡ HerAI
Financial distress indicators · updated 2026-10-08

Tilray Brands, Inc. — financial distress indicators

TLRY — open full stock page →
HealthcareDrug Manufacturers - Specialty & Generic Mkt cap $504.12MStatements as of May 2026 Flows: FY May 2026
78VERY WEAK
Distress score / 100
Statistical model output from public data — not an allegation of insolvency or default. Methodology

Financial-health summary

Tilray Brands, Inc.'s reported numbers place it in the 'Very weak' financial-health band (distress score 78/100). The main indicators are operating profit does not cover interest, market-implied default probability >20% and losses in each of the last 3 years. Independently, the Ohlson accounting model puts its 1-year failure probability at 12% and the market-implied (Merton) default probability is 47.0%. In its favour: strong current ratio (2.21).

2.21
Current ratio
-1.85×
Interest cover
42.15×
Debt / EBITDA
27 mo
Cash runway
12%
Ohlson 1-yr PD
47.0%
Merton 1-yr PD
$231.27M
Cash & ST investments
$398.40M
Total debt
-83%
From 52-week high

Stress by dimension

Share price — last 12 months

Indicators behind the score

Each red flag shows the evidence from the company’s own filings and the financial or legal principle behind it. Points add to the 0–100 score.

Operating profit does not cover interest+15
Solvency

Interest coverage (EBIT / interest) is -1.85×.

When EBIT < interest, debt service is funded from cash reserves or new borrowing — the classic precursor to payment default and covenant breach.

Market-implied default probability >20%+15
Market Signal

Merton distance-to-default 0.08 σ → PD 47%.

Structural (Merton/KMV) model: equity is a call option on assets; low distance-to-default means assets are close to the default point.

Losses in each of the last 3 years+12
Profitability

Net income negative in 3 of 3 fiscal years.

Persistent losses erode equity and the capacity to absorb shocks.

Very high leverage+10
Solvency

Total debt is 42.1× EBITDA.

Debt above ~6× EBITDA is deep sub-investment-grade territory; refinancing becomes difficult when rates or earnings move against the company.

Operations consume cash+10
Cash Flow

Operating cash flow negative in 3 of the last 3 years.

A business that cannot fund itself from operations depends on external capital to survive.

Share price down >80% from 52-week high+10
Market Signal

Price is -83% from its 52-week high.

Equity markets price distress early; collapses of this size usually reflect fear of wipe-out in a restructuring.

Heavy shareholder dilution+6
Market Signal

Share count up +24% in a year.

Large issuance usually funds operating losses rather than growth.

Revenue vs net income

Cash generation

Debt vs cash vs equity

✅ Mitigating factors

  • Strong current ratio (2.21).
  • Revenue still growing (+11% YoY).

Frequently asked questions

What do Tilray Brands, Inc.'s financial-health indicators show?

As of 2026-10-08, Tilray Brands, Inc.'s public financial data places it in the 'Very weak' band with a distress score of 78/100, driven by operating profit does not cover interest, market-implied default probability >20% and losses in each of the last 3 years. This is a statistical screen of reported numbers — it does not mean the company is insolvent, has defaulted or will enter insolvency proceedings.

What is Tilray Brands, Inc.'s financial distress score?

78/100 ('Very weak'). Ohlson O-score -1.96 (model 1-year failure probability 12%). Merton distance-to-default 0.08 σ (model default probability 47.0%).

What works in Tilray Brands, Inc.'s favour?

Strong current ratio (2.21). Revenue still growing (+11% YoY).

How are shareholders treated if a company enters insolvency?

In a Chapter 11 reorganisation the absolute priority rule pays secured lenders, then unsecured creditors, before shareholders — so existing shares are usually cancelled or heavily diluted. In Chapter 7 the company is liquidated and shareholders rarely recover anything.

Other Pharma & Biotech companies with distress indicators

All Pharma & Biotech companies with distress indicators →

Methodology

Score = capped sum of rule-based red flags across seven dimensions (liquidity, solvency, profitability, cash flow, sales trend, market signal, news). Ohlson O-score (1980) gives an accounting-based 1-year failure probability; Merton distance-to-default (Bharath & Shumway 2008) gives a market-implied probability. Financial institutions use a capital-based rule set. Recalculated every trading day from the latest filings, prices and news.

Not a prediction of default or insolvency. This page summarises statistical risk indicators from public data. It does not allege insolvency, default or wrongdoing, and the company may have resources or plans not reflected here (undrawn credit lines, asset sales, parent support, recent capital raises). Verify with the company’s filings (SEC 10-K/10-Q). Not investment or legal advice.